MASI vs TECH · rev $2.09B vs P/E 65, rev $1.22B
Masimo Corporation (MASI) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Masimo Corporation (MASI) is a medical devices company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported MASI revenue for 2024-12-28 was $2.09B. Net income was -$304.9M. Revenue was up 2.3% from 2023-12-30 to 2024-12-28. MASI currently screens at market cap $9.02B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
MASI currently screens at market cap $9.02B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the MASI and TECH stock pages for the full models.
Not investment advice.